- Pre-Clinical Efficacy Services
- News and Publications
- Partner or Invest
- Contact us
Pulmokine, a biopharmaceutical company, develops innovative drug therapies and makes new pulmonary research solutions available to the R&D community.
We are in the pre-clinical phases of a new paradigm for the treatment of Pulmonary Arterial Hypertension (PAH), addressing the underlying causes of the disease.
Pulmonary drug research and testing pose a unique set of challenges. We are offering our proprietary discoveries and solutions to other companies in our field.